Projects

ENRICH-AF - EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2020 - Ongoing

Project Lead

Dr. Denis Xavier

Authors

PI: Dr. Denis Xavier, Co-I: Dr. Padmini Devi

Project Status

ongoing